AI-generated summary
The authors report a randomized, single-blinded controlled trial of the SOLIO Alfa Cure Plus device, which combines low level laser therapy, radio frequency and heat, in 37 patients with chronic low back pain. They found greater pain relief in the device group than in the sham group (42% versus 23%, p = 0.03) and better flexibility change. The abstract describes the study as small and the authors conclude the device may reduce back pain.
- Participants
- 37
- Who or what was studied
- Patients with chronic nonspecific low back pain
- Limits stated in the abstract
- The abstract describes a small sample of 37 patients and reports a single-blinded design, with conclusions stated more strongly than the data may support.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on josr-online.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Sham, Trial registration, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.